13 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
2391701	26	Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.	Squibb Institute For Medical Research
2840498	10	Dimeric 1,4-dihydropyridines as calcium channel antagonists.	State University of New York
3339603	9	Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.	University of Oslo
26101566	14	Optimization of ADME Properties for Sulfonamides Leading to the Discovery of a T-Type Calcium Channel Blocker, ABT-639.	Abbvie
21300721	90	Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.	University of Oxford
11585444	295	From hit to lead. Analyzing structure-profile relationships.	Universities of Lille
	15	Phenyl-glycinol based NK1 receptor antagonists — towards the minimum pharmacophore	TBA
31724859	23	New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H	Universit£
30538065	48	The discovery and optimization of benzimidazoles as selective Na	Pfizer
23812503	55	MICE models: superior to the HERG model in predicting Torsade de Pointes.	Chantest
8377012	2	Polycyclic guanidine alkaloids from the marine sponge Crambe crambe and Ca++ channel blocker activity of crambescidin 816.	University of Brussels
30052039	172	Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties.	Emory University
2142737	14	4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studies.	State University of New York